Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.

Abstract

This experience provides strong evidence for a link between epipodophyllotoxin therapy and secondary AML since none of these children received alkylating agent therapy or irradiation. This serious complication raises concern as to the appropriate use of epipodophyllotoxins in the treatment of childhood ALL.